Potential intermediates for diterpenoid quinones:: Cryptotanshinone, tanshinone IIA, and miltirone

被引：1

作者：

Banerjee, AK ^{[1
]}

Azócar, JA ^{[1
]}

de Carrasco, MCS ^{[1
]}

Mimó, ML ^{[1
]}

机构：

[1] Inst Venezolano Invest Cient, Ctr Quim, Caracas 1020A, Venezuela

来源：

SYNTHETIC COMMUNICATIONS | 2001年 / 31卷 / 16期

关键词：

D O I：

10.1081/SCC-100105126

中图分类号：

O62 [有机化学];

学科分类号：

070303 ; 081704 ;

摘要：

The transformation of the cyclic ethers (1) and (11) to dimethyl tetraol (8) and tetrahydrophenanthrene (14) respectively is described. These compounds proved to be a useful building block for the synthesis of angularly fused diterpenoid quinones.

引用

页码：2471 / 2478

页数：8

共 50 条

[41] Comparative pharmacokinetics and tissue distribution of cryptotanshinone, tanshinone IIA, dihydrotanshinone I, and tanshinone I after oral administration of pure tanshinones and liposoluble extract of Salvia miltiorrhiza to rats
Wang, Daifei
Yu, Weibang
Cao, Lin
Xu, Chuncao
Tan, Guoyao
Zhao, Zhongxiang
Huang, Min
Jin, Jing
BIOPHARMACEUTICS & DRUG DISPOSITION, 2020, 41 (1-2) : 54 - 63
[42] Potential anticancer activity of tanshinone IIA against human breast cancer
Wang, XJ
Wei, YQ
Yuan, SL
Liu, GJ
Lu, YR
Zhang, J
Wang, WD
INTERNATIONAL JOURNAL OF CANCER, 2005, 116 (05) : 799 - 807
[43] Potential Therapeutic Roles of Tanshinone IIA in Human Bladder Cancer Cells
Chiu, Sheng-Chun
Huang, Sung-Ying
Chang, Shu-Fang
Chen, Shee-Ping
Chen, Chi-Cheng
Lin, Tien-Huang
Liu, Hsin-Ho
Tsai, Tsung-Hsun
Lee, Shang-Sen
Pang, Cheng-Yoong
Hsieh, Teng-Fu
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2014, 15 (09): : 15622 - 15637
[44] Down regulation of pro-inflammatory pathways by tanshinone IIA and cryptotanshinone in a non-genetic mouse model of Alzheimer's disease
Maione, Francesco
Piccolo, Marialuisa
De Vita, Simona
Chini, Maria Giovanna
Cristiano, Claudia
De Caro, Carmen
Lippiello, Pellegrino
Miniaci, Maria Concetta
Santamaria, Rita
Irace, Carlo
De Feo, Vincenzo
Calignano, Antonio
Mascolo, Nicola
Bifulco, Giuseppe
PHARMACOLOGICAL RESEARCH, 2018, 129 : 482 - 490
[45] Progress of tanshinone IIA against respiratory diseases: therapeutic targets and potential mechanisms
Ding, Zhaohui
Deng, Youlin
Luo, Huie
Liu, Cuiwang
Yang, Minjuan
Xue, Hanrong
Chen, Zhengtao
FRONTIERS IN PHARMACOLOGY, 2025, 16
[46] Simultaneous quantification of cryptotanshinone and its active metabolite tanshinone IIA in plasma by liquid chromatography/tandem mass spectrometry (LC-MS/MS)
Hao, HP
Wang, GJ
Li, P
Li, J
Ding, ZQ
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2006, 40 (02) : 382 - 388
[47] Activation of CYP3A-mediated testosterone 6β-hydroxylation by tanshinone IIA and midazolam 1-hydroxylation by cryptotanshinone in human liver microsomes
Qiu, Furong
Zhang, Rong
Wang, Guangji
Gao, Chenglu
Sun, Jianguo
Jiang, Jian
Ma, Yueming
XENOBIOTICA, 2010, 40 (12) : 800 - 806
[48] Cardiovascular actions and therapeutic potential of tanshinone IIA (vol 220, pg 3, 2012)
Gao, Si
Liu, Zhiping
Li, Hong
Little, Peter J.
Liu, Peiqing
Xu, Suowen
ATHEROSCLEROSIS, 2012, 221 (02) : 604 - 604
[49] Pharmacokinetics of Caffeic Acid, Ferulic Acid, Formononetin, Cryptotanshinone, and Tanshinone IIA after Oral Administration of Naoxintong Capsule in Rat by HPLC-MS/MS
Li, Jin
Bai, Yang
Bai, Yun
Zhu, Ruichao
Liu, Wei
Cao, Jun
An, Mingrui
Tan, Zhijing
Chang, Yan-xu
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2017, 2017
[50] In vitro and computational insights revealing the potential inhibitory effect of Tanshinone IIA against influenza A virus
Elebeedy, Dalia
Badawy, Ingy
Elmaaty, Ayman Abo
Saleh, Moustafa M.
Kandeil, Ahmed
Ghanem, Aml
Kutkat, Omnia
Alnajjar, Radwan
Abd El Maksoud, Ahmed, I
Al-karmalawy, Ahmed A.
COMPUTERS IN BIOLOGY AND MEDICINE, 2022, 141

← 1 2 3 4 5 →